Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The "nice movement today" is a continuation mo from last week. Do some DD & you'll know what you just bought.
Yes, the 75:1 RS was announced but buried in a PR a couple of months ago.
I agree with your observations here about F*tb*t's inexperience & lack of decorum on this board re: RLFTF. He doesn't learn anything by continuing to spew forth all of his negativity.
I agree with your sentiments about Relief Therapeutics, altho not as intensely.
Likewise. The 2 leaders of this Co. are very smart and really stand-up guys!
Cannabis/MJ is going to really take off this year coz Biden Admin is already preparing legislation to decriminalize MJ on the Federal level!
Same here. Gotta hold strong to get to the 'promised land'!
Don't you mean 'higher lows'?
The news already hit on Tue. that SFOR has eliminated all but $43k toxic debt and has raised $2.3M to market their 2 security software products. Preparing to uplist to OTCQB very soon.
NeuroRx, as I'm sure you're aware, is in the process of becoming it's own publicly-traded company on NASDAQ via a SPAC-Merger with Big Rock Partners Acquisition-BRPA. So, they're trying to distance themselves frm Relief Therap. as best they can w/o alienating Relief
I did with ENZC in Dec. when it ripped, but I sold off too soon & missed the rest of the trip.
Good going! You deserve it for hanging in there thru thick 'n thin.
It looks like it's headed for another run.
Plus, RLFTF has 3.6Bill OS, which would make the Co. way Overvalued once the sp shoots up.
If the Topline results turn out really well, then it will be the 1st Proven Therapeutic to Save the Lives of Critical Covid-19 Pts. which will probably launch the stock to the stratosphere.
This is a legitimate scenario that Relief is undertaking since they may not have the capacity to mass produce & distribute Zyesami if EUA is issued.
The EUA was denied; Dr. Javitt even said so when interviewed.
All of these are very good questions worth getting answers to.
Any minute it'll hit $1!
It's no different from our Gov't's promised rollout dates & numbers with the Covid-19 Vaccines.
RLFTF gains have been comparable to BRPA; We've run up frm .38 to .58 in the past week, very similar to BRPA's gain frm 35 to 58.
I agree with dmsrz8. Stop your belly-aching drama.
Why do you say the trial results are "delayed"? Relief never gave any specific date for the results. Only "late Jan./early Feb."
Insiders already own gazillion shares; pps is going down currently due to MMs or Daytraders.
Since Relief owns the drug and is the trading co., I would think it's Relief that does the honors of releasing the Topline data results.
I agree or else I wouldn't have bought shares.
I'm wondering why the below PR of "LOI to Acquire EnergyWyze" isn't pinned on this board? It's a major PR, don't you think?
PHOENIX, Jan. 12, 2021 /PRNewswire/ -- SinglePoint Enters Into Letter of Intent (LOI) to Acquire EnergyWyze, LLC to Streamline, Optimize, and Maximize Solar Industry Lead
https://finance.yahoo.com/news/singlepoint-enters-letter-intent-acquire-133000059.html
Yes, I did notice those 'flash trade' lows. Did those trades happen coz the traders had set their limit prices that low?
Short 58% is pretty substantial. Thanks for being proactive about this.
RLF Swiss is already up 10% in 1st hr. and more than 1/2 avg. daily volume.
If you've been following the PRs at all, CELZ already submitted their IND for Treatment of Stroke to the FDA 2 wks ago. The FDA should be responding w/the greenlight next mo.(if all goes well), which will launch this stock!
What makes you say that? Scared of what?
RS is a good thing; so they can uplist to NASDAQ a lot sooner & attract bigtime institutional investors.
There's not much to this article, and it's not even encouraging about "Zyesami"s therapeutic value (no longer known as Aviptadil/Relief-100). It doesn't even say that Ph.3 Trial results are pending; only that it's in clinical trials.
I agree. That would account for the abrupt shoot up & drop back down in pps.
One stock's Brain Cancer Ph.3 trial results were only due to come out soon, and its pps went frm .60 to $2+. They didn't release the results when expected & it went down to $1.
What tweet?!?
They have an acquisition in the works that'll give them some substantive revenue; they're going to finalize the Definitive Agreement very soon.
Yes, they said in one of their PRs in order to uplist to a national exchange, they're planning a 1:75 RS to up their pps into dollars.
I'll try & slap the Ask at the open to squeeze the shorts, too!